Unbiased Analysis of Today's Healthcare Issues

Economic Dimensions of Personalized and Precision Medicine

Written By: Jason Shafrin - Sep• 21•16

I am attending a National Bureau of Economic Research (NBER) Pre-Conference on Economic Dimensions of Personalized and Precision Medicine. You can find the meeting agenda here. The speakers today were very interesting and touched on a number of topics with respect to precision medicine including:

  • Measuring the value of a precision medicine diagnostic test
  • Determining the appropriate cost sharing for precision medicine under various conditions
  • Examining whether the hype behind genome-wide association study (GWAS) was warrented
  • Considering the game theoretic implications for innovators for targeting broader compared to more precise patient populations
  • Estimating the value that could be generated from personalized medicine due to better treatment targeting in multiple sclerosis
  • Characterizing the drug development pipeline for precision medicines

My presentations is tomorrow. So far it’s been a blast.

You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Your email address will not be published. Required fields are marked *